Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOSAMBA Clinical Trial - Stage I
NCT04540692Phase 3Active, not recruiting
- Sponsor
- Latin American Cooperative Oncology Group
- Start
- Jan 2021
- Primary completion
- Apr 2027
- Modality
- DNA Intercalators/Alkylators, Targeted Liposomes, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated liposomal doxorubicin, cyclophosphamide, docetaxel, Paclitaxel Micelles for Injection in breast cancer, sponsored by Latin American Cooperative Oncology Group. Started Jan 2021; status: active, not recruiting.
02
Drugs
pegylated liposomal doxorubicincyclophosphamidedocetaxelPaclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04540692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04540692.